| Literature DB >> 33854198 |
Yizhou Wen1, Xianmin Wang2, Yonghong Guo1, Mei Jin1, Jimei Xi1, Tingting Chen1, Kun Shi1, Yaheng Lu1.
Abstract
Coronary artery abnormalities (CAAs) are a severe complication of Kawasaki disease (KD) that may lead to cardiovascular events. Given the evidence that brachial artery flow-mediated dilation (FMD) decreases in children after the onset of KD, we hypothesized that it could be an early marker of CAA development in the acute stage and investigated its relationship with variation in the coronary artery diameter. A total of 326 sex- and age-matched children were enrolled, including 120 with KD, 109 febrile children and 97 healthy controls. In this study, FMD was significantly decreased in the KD group compared with the febrile and healthy groups. FMD was lower in the CAA group than in the no coronary artery abnormality group. The comparison of FMD showed an obvious difference among the CAA subgroups. The FMD in the coronary aneurysm (CA) group showed a strong negative correlation with the pretreatment maximum coronary artery Z-score (preZmax). While preZmax was 2.5, the receiver operating characteristic curve indicated an optimal cutoff point of 3.44% for FMD. FMD ≤ 3.44% could be considered as a signal of coronary lesions in acute stage of KD.Entities:
Year: 2021 PMID: 33854198 PMCID: PMC8046814 DOI: 10.1038/s41598-021-87704-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Participant flow diagram.
Clinical characteristics and ultrasonography features of KD, Febrile and Healthy groups.
| n | Age* | Male* | BMI* | BBD* | preZmax** | |
|---|---|---|---|---|---|---|
| (years) | n(%) | (kg/m2) | (mm) | |||
| KD | 105 | 2.92 ± 1.86 | 62(59.0) | 16.07 ± 1.35 | 1.95 ± 0.53 | 2.57 ± 2.91 |
| Febrile | 92 | 2.77 ± 1.73 | 51(55.4) | 15.99 ± 1.31 | 2.07 ± 0.54 | 0.92 ± 1.09 |
| Healthy | 79 | 3.21 ± 1.82 | 45(57.0) | 16.02 ± 1.22 | 2.04 ± 0.56 | 0.76 ± 1.12 |
| 0.265 | 0.876 | 0.927 | 0.283 | < 0.01 |
The data are presented as the mean ± SD for continuous variables and as the percentage for the categorical variables. BMI body mass index; BBD brachial baseline diameter; preZmax maximum coronary artery z-score; FMD flow-mediated dilation.*P > 0.05(KD v.s. Febrile, KD v.s. Healthy),**P < 0.01(KD v.s. Febrile, KD v.s. Healthy).
Figure 2Coronary segment distribution of the preZmax in different groups. The number shows the percentage of coronary segment which the preZmax came from.
Figure 3Comparison and distribution of flow-mediated dilation (FMD) among groups. KD Kawasaki disease; Feb febrile (controls); Hea healthy (controls); CAA coronary artery abnormality; NCAA no coronary artery abnormality; CA coronary aneurysm; NCA no coronary aneurysm; MD mild dilation; SCA small coronary aneurysm; MCA middle coronary aneurysm; LCA large coronary aneurysm. Box plots showing (a) comparison of FMD among the KD, febrile and healthy groups; (b) comparison of FMD between the CAA and NCAA groups; (c) comparison of FMD between the CA and NCA groups; (d) distribution of FMD among the subgroups of CAA group. (*P < 0.01; **P > 0.05). Circles denote outlier cases, and squares denote extreme cases.
Figure 4Correlation between flow-mediated dilation (FMD) and pretreatment maximum coronary artery Z-score (preZmax) in groups. KD Kawasaki disease; Feb febrile (controls); Hea healthy (controls); CA coronary aneurysm; NCA no coronary aneurysm; CAA coronary artery abnormality; NCAA no coronary artery abnormality; MD mild dilation; SCA small coronary aneurysm; MCA middle coronary aneurysm; LCA large coronary aneurysm. Scatter plots showing (a) correlation between FMD and preZmax in the KD, febrile and healthy groups; (b) correlation between FMD and preZmax in the CA and NCA groups; (c) correlation between FMD and preZmax in the CAA and NCAA groups; (d) correlation between FMD and preZmax in the CAA subgroups.
Figure 5(a) Receiver operating characteristic (ROC) curve analysis for flow-mediated dilation (FMD) in predicting coronary dilation (preZmax > 2.0) during acute Kawasaki disease. (b) ROC curve analysis for FMD in predicting coronary aneurysm (preZmax ≥ 2.5) during acute Kawasaki disease. AUC* area under the curve.